Juncture Wealth Strategies, LLC Corcept Therapeutics Inc Transaction History

Juncture Wealth Strategies, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 15, 2021	SELL	$23.49 - $30.56 $313,121 - $407,364	-13,330 Closed	0 $0
Q4 2020 Jan 25, 2021	SELL	$16.78 - $27.3 $185,603 - $301,965	-11,061 Reduced 45.35%	13,330 $349,000
Q3 2020 Oct 15, 2020	BUY	$12.46 - $19.98 $22,552 - $36,163	1,810 Added 8.02%	24,391 $425,000
Q2 2020 Jul 28, 2020	BUY	$11.0 - $18.26 $248,391 - $412,329	22,581 New	22,581 $380,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Juncture Wealth Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Juncture Wealth Strategies, LLC with notifications on news.